Harvard Bioscience (HBIO) Change in Cash (2010 - 2026)
Harvard Bioscience (HBIO) reported Change in Cash of -$1.5 million for Q1 2026, down 205.42% year-over-year from $1.4 million in Q1 2025, and down 184.36% quarter-over-quarter from $1.8 million in Q4 2025.
Harvard Bioscience (HBIO) Change in Cash (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Change in Cash data on file, last reported at -$1.5 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$1.5 million, down 205.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 20.22% YoY), and the FY2025 annual result was $4.5 million, up 2674.86% from the prior year.
- Change in Cash slipped to -$1.5 million in Q1 2026 per HBIO's latest filing, from $1.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $1.9 million in Q2 2025 and troughed at -$2.4 million in Q1 2022.
- A 5-year average of -$42529.4 and a median of -$207000.0 in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash plunged 378.2% in 2022, then surged 5235.71% in 2025.
- A 5-year view of Change in Cash shows it stood at -$636000.0 in 2022, then slumped by 66.19% to -$1.1 million in 2023, then soared by 56.39% to -$461000.0 in 2024, then surged by 489.8% to $1.8 million in 2025, then tumbled by 184.36% to -$1.5 million in 2026.
- Business Quant data shows HBIO's Change in Cash at -$1.5 million in Q1 2026, $1.8 million in Q4 2025, and -$625000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.36 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 64.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 296.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 243.44 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -269.90 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -318.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 14.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -35.05 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 51.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | -625,000.00 |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | -461,000.00 |
| Sep 30, 2024 | 521,000.00 |
| Jun 30, 2024 | -207,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -1.06 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 535,000.00 |
| Mar 31, 2023 | -719,000.00 |
| Dec 31, 2022 | -636,000.00 |
| Sep 30, 2022 | 885,000.00 |
| Jun 30, 2022 | -1.17 Mn |
| Mar 31, 2022 | -2.39 Mn |
| Dec 31, 2021 | 2.27 Mn |
| Sep 30, 2021 | -689,000.00 |
| Jun 30, 2021 | 422,000.00 |